Cost-utility analysis of daily versus intermittent inhaled corticosteroids in mild-persistent asthma-Reference-Cited by-同舟云学术

Cost-utility analysis of daily versus intermittent inhaled corticosteroids in mild-persistent asthma

Published:2014-06-25 Issue:8 Volume:50 Page:735-746
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr Pulmonol.

Author:

Rodriguez-Martinez Carlos E.¹²,Nino Gustavo³,Castro-Rodriguez Jose A.⁴

Affiliation:

1. Department of Pediatrics; School of Medicine; Universidad Nacional de Colombia; Bogota Colombia

2. Research Unit; Military Hospital of Colombia; Bogota Colombia

3. Division of Pediatric Pulmonary; Sleep Medicine and Integrative Systems Biology, Center for Genetic Research, Children's National Medical Center, George Washington University; Washington District of Columbia

4. Department of Pediatrics and Family Medicine; School of Medicine, Pontificia Universidad Catolica de Chile; Santiago Chile

Funder

National Institute of Health (NIH) Career Development Award

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ppul.23073/fullpdf

Reference34 articles.

1. Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma;Johansson;Pharmaeconomics,2006

2. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway responsiveness and clinical asthma in nonsteroid dependent asthmatics;Juniper;Am Rev Respir Dis,1990

3. Comparison of a β2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma;Haahtela;N Engl J Med,1991

4. The inhaled steroid treatment as regular therapy in early asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma;Busse;J Allergy Clin Immunol,2008

5. Low-dose inhaled corticosteroids and the prevention of death from asthma;Suissa;N Engl J Med,2000

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-utility analysis of palivizumab for preventing respiratory syncytial virus in preterm neonates and infants in Colombia;BMC Infectious Diseases;2024-04-19

2. Cost-utility analysis of prenatal supplementation with long-chain n-3 fatty acids to reduce the incidence of wheezing and asthma in neonates;Journal of Asthma;2024-03-04

3. Cost-utility analysis of palivizumab for preventing respiratory syncytial virus in preterm neonates and infants in Colombia;2023-08-04

4. The Use of Bacterial Lysate for the Prevention of Wheezing Episodes in Preschool Children: A Cost-Utility Analysis;The Journal of Allergy and Clinical Immunology: In Practice;2023-01

5. Cost Utility of Intermittent Inhaled Corticosteroids in Preschoolers with Viral-Triggered Wheeze;Pediatric Allergy, Immunology, and Pulmonology;2022-03-01